Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Biora Therapeutics, Inc.
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 15, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update
May 08, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer
May 01, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference
April 20, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
March 30, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
March 23, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
February 23, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery Platform
February 16, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Presents Data from Device Performance Study with Repeat Doses in Both Fasted and Fed States at Crohn’s & Colitis Congress
January 19, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
January 09, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Reverse Stock Split
December 30, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Two Poster Presentations at the Crohn’s & Colitis Congress
December 08, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development
November 29, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 14, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
November 07, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
October 25, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
October 24, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
October 19, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
October 10, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in Upcoming BTIG Investment Conference
July 26, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.